Literature DB >> 22155015

Genes, tolerance and systemic autoimmunity.

Ram P Singh1, Richard T Waldron, Bevra H Hahn.   

Abstract

The characterization of functional CD8(+) inhibitory or regulatory T cells and their gene regulation remains a critical challenge in the field of tolerance and autoimmunity. Investigating the genes induced in regulatory cells and the regulatory networks and pathways that underlie mechanisms of immune resistance and prevent apoptosis in the CD8(+) T cell compartment are crucial to understanding tolerance mechanisms in systemic autoimmunity. Little is currently known about the genetic control that governs the ability of CD8(+) Ti or regulatory cells to suppress anti-DNA Ab production in B cells. Silencing genes with siRNA or shRNA and overexpression of genes with lentiviral cDNA transduction are established approaches to identifying and understanding the function of candidate genes in tolerance and immunity. Elucidation of interactions between genes and proteins, and their synergistic effects in establishing cell-cell cross talk, including receptor modulation/antagonism, are essential for delineating the roles of these cells. In this review, we will examine recent reports which describe the modulation of cells from lupus prone mice or lupus patients to confer anti-inflammatory and protective gene expression and novel associated phenotypes. We will highlight recent findings on the role of selected genes induced by peptide tolerance in CD8(+) Ti.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155015      PMCID: PMC3306516          DOI: 10.1016/j.autrev.2011.11.017

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  111 in total

1.  Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells.

Authors:  Hee-Kap Kang; Michael Liu; Syamal K Datta
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

Review 2.  CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects.

Authors:  S M Kang; Q Tang; J A Bluestone
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

3.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

Authors:  M L Cleary; S D Smith; J Sklar
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

4.  Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells.

Authors:  Gabriela Riemekasten; Dirk Langnickel; Philipp Enghard; Reinmar Undeutsch; Jens Humrich; Fanny M Ebling; Berthold Hocher; Tiina Humaljoki; Hans Neumayer; Gerd-R Burmester; Bevra H Hahn; Andreas Radbruch; Falk Hiepe
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

5.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

6.  The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model.

Authors:  Amir Sharabi; Dror Luger; Hava Ben-David; Molly Dayan; Heidey Zinger; Edna Mozes
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

7.  Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.

Authors:  C S Via; S O Sharrow; G M Shearer
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

8.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

9.  CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.

Authors:  Ram Pyare Singh; Antonio La Cava; Maida Wong; Fanny Ebling; Bevra H Hahn
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  12 in total

Review 1.  Gene Therapy for Autoimmune Disease.

Authors:  Shang-An Shu; Jinjun Wang; Mi-Hua Tao; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 2.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 3.  Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.

Authors:  Divaker Choubey
Journal:  Immunol Lett       Date:  2012-07-24       Impact factor: 3.685

4.  Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.

Authors:  Amit K Maiti; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

5.  New insights into the catalytic mechanism of histidine phosphatases revealed by a functionally essential arginine residue within the active site of the Sts phosphatases.

Authors:  Boris San Luis; Nicolas Nassar; Nick Carpino
Journal:  Biochem J       Date:  2013-07-01       Impact factor: 3.857

Review 6.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 7.  Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Clin Dev Immunol       Date:  2012-06-14

8.  Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice Model.

Authors:  Ahmad Hosseini; Hajar Estiri; Haleh Akhavan Niaki; Akram Alizadeh; Baharak Abdolhossein Zadeh; Sayyed Mohammad Hossein Ghaderian; Akbar Farjadfar; Ali Fallah
Journal:  Cell J       Date:  2017-08-19       Impact factor: 2.479

Review 9.  Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

10.  Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).

Authors:  Gregg E Dinse; Christine G Parks; Clarice R Weinberg; Helen C S Meier; Caroll A Co; Edward K L Chan; Frederick W Miller
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.